News European regulators back Chiesi COPD triple therapy Chiesi takes on Seretide and other lung drugs with Trimbow.
News Shareholder’s exit from ‘frustrating’ GSK a blow for Walmsle... 'Continuity candidate' Emma Walmsley won't deliver the shake-up GSK needs, says Woodford
News GSK gets short term boost as second US Advair generic reject... FDA rejects Hikma drug, regulator has "major" issue with Mylan's rival.
News AZ failure cast further doubts over IL-13 drug asthma class AZ waits for second set of results due later this year.
News AZ hopes to boost respiratory pipeline with Pieris deal AstraZeneca is hoping to boost its respiratory pipeline in a deal potentially worth more than $2 billion with US biotech Pieris Pharmaceuticals.
News Blue Shield of California bypasses PBMs to slash Humira pric... Blue Shield of California is pioneering a strategy that bypasses traditional pharmacy benefit managers to slash the price of Humira by up to 90%
R&D Sponsored Beyond clinical: Boosting recruitment and retention with SDO... The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care.